Terms: = Leukemia AND SETD2, ENSG00000181555, 29072 AND Diagnosis
9 results:
1. Tyrosine kinase inhibitor resistance in de novo BCR::ABL1-positive BCP-ALL beyond kinase domain mutations.
van Outersterp I; Boer JM; van de Ven C; Reichert CEJ; Boeree A; Kruisinga B; de Groot-Kruseman HA; Escherich G; Sijs-Szabo A; Rijneveld AW; den Boer ML
Blood Adv; 2024 Apr; 8(8):1835-1845. PubMed ID: 38386975
[TBL] [Abstract] [Full Text] [Related]
2. Cytogenetics in the management of mature T-cell and NK-cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Gaillard JB; Chapiro E; Daudignon A; Nadal N; Penther D; Chauzeix J; Nguyen-Khac F; Veronese L; Lefebvre C
Curr Res Transl Med; 2023; 71(4):103428. PubMed ID: 38016421
[TBL] [Abstract] [Full Text] [Related]
3. Deep Molecular Response Achieved with Chemotherapy, Dasatinib and Interferon α in Patients with Lymphoid Blast Crisis of Chronic Myeloid Leukaemia.
Vráblová L; Divoký V; Kořalková P; Poláková KM; Kriegová E; Janská R; Grohmann J; Holzerová M; Papajík T; Faber E
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768374
[TBL] [Abstract] [Full Text] [Related]
4. The clinical outcomes and genomic landscapes of acute lymphoblastic leukemia patients with E2A-PBX1: A 10-year retrospective study.
Zhou B; Chu X; Tian H; Liu T; Liu H; Gao W; Chen S; Hu S; Wu D; Xu Y
Am J Hematol; 2021 Nov; 96(11):1461-1471. PubMed ID: 34406703
[TBL] [Abstract] [Full Text] [Related]
5. The hematopoietic stem cell marker VNN2 is associated with chemoresistance in pediatric B-cell precursor ALL.
Bornhauser B; Cario G; Rinaldi A; Risch T; Rodriguez Martinez V; Schütte M; Warnatz HJ; Scheidegger N; Mirkowska P; Temperli M; Möller C; Schumich A; Dworzak M; Attarbaschi A; Brüggemann M; Ritgen M; Mejstrikova E; Hofmann A; Buldini B; Scarparo P; Basso G; Maglia O; Gaipa G; Skoblyn TL; Te Kronnie G; Vendramini E; Panzer-Grümayer R; Barz MJ; Marovca B; Hauri-Hohl M; Niggli F; Eckert C; Schrappe M; Stanulla M; Zimmermann M; Wollscheid B; Yaspo ML; Bourquin JP
Blood Adv; 2020 Sep; 4(17):4052-4064. PubMed ID: 32853382
[TBL] [Abstract] [Full Text] [Related]
6. Hepatosplenic T-cell Lymphoma: a review of clinicopathologic features, pathogenesis, and prognostic factors.
Yabe M; Miranda RN; Medeiros LJ
Hum Pathol; 2018 Apr; 74():5-16. PubMed ID: 29337025
[TBL] [Abstract] [Full Text] [Related]
7. Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing.
Masetti R; Castelli I; Astolfi A; Bertuccio SN; Indio V; Togni M; Belotti T; Serravalle S; Tarantino G; Zecca M; Pigazzi M; Basso G; Pession A; Locatelli F
Oncotarget; 2016 Aug; 7(35):56746-56757. PubMed ID: 27462774
[TBL] [Abstract] [Full Text] [Related]
8. Mutations in epigenetic regulators are involved in acute lymphoblastic leukemia relapse following allogeneic hematopoietic stem cell transplantation.
Xiao H; Wang LM; Luo Y; Lai X; Li C; Shi J; Tan Y; Fu S; Wang Y; Zhu N; He J; Zheng W; Yu X; Cai Z; Huang H
Oncotarget; 2016 Jan; 7(3):2696-708. PubMed ID: 26527318
[TBL] [Abstract] [Full Text] [Related]
9. Mutations in epigenetic regulators including setd2 are gained during relapse in paediatric acute lymphoblastic leukaemia.
Mar BG; Bullinger LB; McLean KM; Grauman PV; Harris MH; Stevenson K; Neuberg DS; Sinha AU; Sallan SE; Silverman LB; Kung AL; Lo Nigro L; Ebert BL; Armstrong SA
Nat Commun; 2014 Mar; 5():3469. PubMed ID: 24662245
[TBL] [Abstract] [Full Text] [Related]
